D. E. Shaw & Co., Inc. Ultragenyx Pharmaceutical Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q4 2017 Feb 14, 2018	SELL	$43.54 - $57.32 $435,400 - $573,200	-10,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$49.79 - $66.32 $497,900 - $663,199	10,000	10,000 $533,000

344

86.6M

675K

846K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.98B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.